[Skystar Bio-Pharmaceutical Company Announces Third Quarter 2009 Financial Results Company Reports Record Quarterly Revenue of $12.78 Million and Adjusted Net Income of $4.25 Million; and Adjusted EPS of $0.61 Per Share XI'AN, CHINA – November 16, 2009 – Skystar Bio-Pharmaceutical Company (NASDAQ: SKBI) THIRD QUARTER 2009 HIGHLIGHTS § Revenue increased 27.1% period over period to $12.78 million. § Gross margin]

[Skystar Bio-Pharmaceuticalmpany Announces Third Quarter 2009 Financial Resultsmpany Reports Record Quarterly Revenue of $12.78 Million andjusted Netome of $4.25 Million; andjusted EPS of $0.61 Per Share XI'AN, CHINA November 16, 2009ystar Bio-Pharmaceuticalmpany (NASDAQ:BI) THIRD QUARTER 2009 HIGHLIGHTS Revenuereased 27.1% period over period to $12.78 million.]

[Skystar to Present at the Brean Murray Carret & Co. 2009 China Growth Conference XI'AN, CHINA — November 11 , 2009 — Skystar Bio-Pharmaceutical Company skystar@tpg-ir.com To request a one-on-one meeting or to be added to Skystar’s email list, please contact Brandi Floberg at About Skystar Bio-Pharmaceutical Company http://www.skystarbio-pharmaceutical.com Skystar is a China-based developer and distributor of veterinary healthcare and]

[Skystar to Present at the Brean Murrayrret & 2009 China Growthnference XI'AN, CHINA November 11 , 2009ystar Bio-Pharmaceuticalmpanyystar@tpg-ir.com To request a one-on-one meeting or to beded toystars email list, pleasentact Brandi Floberg atoutystar Bio-Pharmaceuticalmpany http://www.skystarbio-pharmaceutical.comystar is a China-based developer and distributor of veterinary healthcare and medicalre products.ystar has four product lines (veterinary medicines, micro-organisms, vaccines]

[Skystar Bio-Pharmaceutical Company Announces Two-for-One Stock Split XI'AN, CHINA — November 5, 2009 — Skystar Bio-Pharmaceutical Company (NASDAQ: SKBI) Shareholders of record as of the close of market on November 16, 2009 will automatically be entitled to one additional share of common stock for each share owned. No action is required on the part of the shareholders, as the Company’s]